Leonard H. Calabrese, DO - Recognition and Management of Axial Spondyloarthritis: Best Practices for Family Medicine Physicians
Go online to PeerView.com/RBU860 to view the activity, download
slides and practice aids, and complete the post-test to earn
credit.
11 Minuten
Podcast
Podcaster
Thought leader perspectives on current clinical advances in medicine.
Beschreibung
vor 3 Jahren
Go online to PeerView.com/RBU860 to view the activity, download
slides and practice aids, and complete the post-test to earn
credit. In this activity, an expert discusses the recognition of
axial spondyloarthritis (axSpA) and integrating the latest evidence
into the management of patients with axSpA. Upon completion of this
activity, participants should be better able to: Identify the
specific domains of axial spondyloarthritis (axSpA) and their
relationship to quality of life; Apply classification criteria and
diagnostic tests into clinical practice to identify axSpA in
patients with inflammatory back pain; Assess efficacy and safety
data related to novel biologic options for axSpA, recognizing the
potential clinical impact on the management of patients who do not
respond well to traditional pharmacologic therapies; Employ
treatment plans for individual patients with axSpA in accordance
with current evidence, expert recommendations, and patient needs
and preferences; and Collaborate with rheumatologists to provide
optimal treatment and longitudinal support for patients with axSpA.
slides and practice aids, and complete the post-test to earn
credit. In this activity, an expert discusses the recognition of
axial spondyloarthritis (axSpA) and integrating the latest evidence
into the management of patients with axSpA. Upon completion of this
activity, participants should be better able to: Identify the
specific domains of axial spondyloarthritis (axSpA) and their
relationship to quality of life; Apply classification criteria and
diagnostic tests into clinical practice to identify axSpA in
patients with inflammatory back pain; Assess efficacy and safety
data related to novel biologic options for axSpA, recognizing the
potential clinical impact on the management of patients who do not
respond well to traditional pharmacologic therapies; Employ
treatment plans for individual patients with axSpA in accordance
with current evidence, expert recommendations, and patient needs
and preferences; and Collaborate with rheumatologists to provide
optimal treatment and longitudinal support for patients with axSpA.
Weitere Episoden
20 Minuten
vor 5 Monaten
1 Stunde 30 Minuten
vor 5 Monaten
In Podcasts werben
Kommentare (0)